MedTrace Logo

Clinical Study to Examine the Effects of Erythropoietin on Left Ventricular Function After Acute Myocardial Infarction

NCT00449488 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 529

Last updated 2009-12-15

No results posted yet for this study

Summary

The primary objective of this study is to establish the effects of a single bolus of EPO, administered within three hours after a primary PCI for a first acute myocardial infarction, on left ventricular function.

Conditions

Interventions

DRUG

epoetin alfa

epoetin alfa 60.000 IU one i.v. bolus

Sponsors & Collaborators

  • The Interuniversity Cardiology Institute of the Netherlands

    collaborator OTHER_GOV

  • Janssen-Cilag Ltd.

    collaborator INDUSTRY

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • A A Voors, MD,PhD · University Medical Center Groningen

  • F Zijlstra, MD,PhD,FACC · University Medical Center Groningen

  • DJ van Veldhuisen, MD,PhD,FACC · University Medical Center Groningen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00449488 on ClinicalTrials.gov